A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Yi, J.
Ahn, H.
Lee, S.
Uhm, J.
Lee, J.
Park, S.
Park, J.
Park, Y.
Lim, H.
Kang, W.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14655
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14655
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma
    Lee, Su Jin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Lee, Jongtae
    Yim, Dong-Seok
    Lim, Ho Yeong
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1540 - 1547
  • [2] Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma
    Su Jin Lee
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Young Suk Park
    Won Ki Kang
    Jongtae Lee
    Dong-Seok Yim
    Ho Yeong Lim
    Investigational New Drugs, 2012, 30 : 1540 - 1547
  • [3] A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma
    Yoshihiko Ooka
    Tetsuhiro Chiba
    Sadahisa Ogasawara
    Kuniaki Arai
    Eiichiro Suzuki
    Akinobu Tawada
    Tatsuya Yamashita
    Fumihiko Kanai
    Shuichi Kaneko
    Osamu Yokosuka
    Investigational New Drugs, 2014, 32 : 723 - 728
  • [4] A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma
    Ooka, Yoshihiko
    Chiba, Tetsuhiro
    Ogasawara, Sadahisa
    Arai, Kuniaki
    Suzuki, Eiichiro
    Tawada, Akinobu
    Yamashita, Tatsuya
    Kanai, Fumihiko
    Kaneko, Shuichi
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 723 - 728
  • [5] Combination of oxaliplatin and S-1 versus sorafenib alone in patients with advanced hepatocellular carcinoma
    Lv, Yufeng
    Liang, Rong
    Hu, Xiaohua
    Liu, Zhihui
    Liao, Xiaoli
    Lin, Yan
    Yuan, Chunling
    Liao, Sina
    Li, Qian
    Zhang, Jinyan
    Li, Yongqiang
    PHARMAZIE, 2014, 69 (10): : 759 - 763
  • [6] A phase 1/2 study of S-1 with sorafenib in advanced hepatocellular carcinoma
    Ooka, Y.
    Ogasawara, S.
    Kanai, F.
    Arai, K.
    Suzuki, E.
    Tawada, A.
    Chiba, T.
    Yamashita, T.
    Kaneko, S.
    Yokosuka, O.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S628 - S628
  • [7] A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
    Lee, Dae-Won
    Lee, Kyung-Hun
    Kim, Hee-Jun
    Kim, Tae-Yong
    Kim, Jin-Soo
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Jee Hyun
    Im, Seock-Ah
    Kim, Tae-You
    BMC CANCER, 2018, 18
  • [8] A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
    Dae-Won Lee
    Kyung-Hun Lee
    Hee-Jun Kim
    Tae-Yong Kim
    Jin-Soo Kim
    Sae-Won Han
    Do-Youn Oh
    Jee Hyun Kim
    Seock-Ah Im
    Tae-You Kim
    BMC Cancer, 18
  • [9] A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer
    Kim, Richard
    Tan, Elaine
    Wang, Emily
    Mahipal, Amit
    Chen, Dung-Tsa
    Cao, Biwei
    Masawi, Fadzai
    Machado, Cindy
    Yu, James
    Kim, Dae Won
    ONCOLOGIST, 2020, 25 (12): : E1893 - E1899
  • [10] Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial
    Richly, H.
    Schultheis, B.
    Adamietz, I. A.
    Kupsch, P.
    Grubert, M.
    Hilger, R. A.
    Ludwig, M.
    Brendel, E.
    Christensen, O.
    Strumberg, D.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (04) : 579 - 587
12345